Terms: = Liver cancer AND POU2AF1, OBF1, 5450, ENSG00000110777, BOB1, OCAB, Q16633, OBF-1 AND Treatment
3 results:
1. Risk factors and actionable molecular signatures in COVID-19-associated lung adenocarcinoma and lung squamous cell carcinoma patients.
Ullah MA; Alam S; Moin AT; Ahamed T; Shohael AM
Comput Biol Med; 2023 May; 158():106855. PubMed ID: 37040675
[TBL] [Abstract] [Full Text] [Related]
2. Trends and Patterns of Disparities in cancer Mortality Among US Counties, 1980-2014.
Mokdad AH; Dwyer-Lindgren L; Fitzmaurice C; Stubbs RW; Bertozzi-Villa A; Morozoff C; Charara R; Allen C; Naghavi M; Murray CJ
JAMA; 2017 Jan; 317(4):388-406. PubMed ID: 28118455
[TBL] [Abstract] [Full Text] [Related]
3. Very late relapse of PTLD 10 yr after allogeneic HSCT and nine yr after stopping immunosuppressive therapy.
Helgestad J; Rosthøj S; Pedersen MH; Johansen P; Iyer V; Østergaard E; Heilmann C
Pediatr Transplant; 2014 Feb; 18(1):E35-9. PubMed ID: 24168387
[TBL] [Abstract] [Full Text] [Related]